Connective Tissue Manipulation and Combined Ultrasound Therapy in Patients with Fibromyalgia
Short and Long Term Results of Connective Tissue Manipulation and Combined Ultrasound Therapy in Patients with Fibromyalgia
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of this study was to evaluate the short term and one year follow-up results of connective tissue manipulation and combined ultrasound therapy (ultrasound and high voltage pulsed galvanic stimulation) in terms of pain, complaint of non-restorative sleep and impact on the functional activities in patients with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2003
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 14, 2006
CompletedFirst Posted
Study publicly available on registry
March 15, 2006
CompletedMarch 14, 2025
March 1, 2006
1.3 years
March 14, 2006
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pain intensity
The intensity of pain was evaluated by 0-10 cm visual analogue scales (VASs). On the VAS, "0" indicated "no pain" and the "10" indicated "the worst imaginable pain".
All evaluations were performed before and after 20 sessions of treatment.
Interventions
Eligibility Criteria
The sample was derived from a population of 83 FM outpatients of the Hacettepe University School of Physical Therapy and Rehabilitation
You may qualify if:
- Women with pain depending to FM, with an intensity interfering to activities of daily living for a duration of at least six months, able to participate of 20 physiotherapy sessions within a four week period, volunteer for participating to the study without taking any drugs acting on the nervous system such as antidepressants, myorelaxants, analgesics or hypnotics, in the study period.
You may not qualify if:
- evidence of neurological, infectious, endocrine and other inflammatory rheumatic diseases, and experience with any kind of manual and/or electrotherapy, within six months before the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University, School of Physical Therapy and Rehabilitation
Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
İlkim Çıtak Karakaya, PT. PhD.
PT. PhD. Assist. Prof.
- STUDY DIRECTOR
Türkan Akbayrak, PT. PhD.
PT. PhD. Assoc. Prof.
- STUDY CHAIR
Funda Demirtürk, PT. PhD.
Research assistant
- STUDY CHAIR
Gamze Ekici, PT. MSc.
Research assistant
- STUDY CHAIR
Yeşim Bakar, PT. PhD.
Assist. Prof.
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
March 14, 2006
First Posted
March 15, 2006
Study Start
August 1, 2003
Primary Completion
December 1, 2004
Study Completion
December 1, 2004
Last Updated
March 14, 2025
Record last verified: 2006-03